TidalSense, a Cambridge, UK-based AI respiratory diagnostics company, raised £14.2 million in a funding round led by Cross-Border Impact Ventures with participation from BGF, Airstream Capital, and others.
More on UK Tech News →
07/25/2026
Transcripta Bio
Transcripta Bio raises $24M follow-on
Transcripta Bio, a Palo Alto-based AI-driven neurology drug discovery...
